Related Experiment Video
Updated: Jan 28, 2026

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
Efficacy of subcutaneous immunotherapy in a mouse model of Humulus pollen-induced allergic asthma
1Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China.
Objective:
The aim of this study was to evaluate the therapeutic effect of subcutaneous injection of high-dose of Humulus pollen allergen on a mouse model of allergic asthma.
Method:
Humulus pollen-sensitized mice received either regular subcutaneous injections of Humulus pollen allergen extract or control treatment were sacrificed. Airway responsiveness, pulmonary inflammatory cell infiltration, serum cytokine secretion and serum immunoglobulin E (IgE) and G2a (IgG2a) levels were measured.
Result:
Our results showed that subcutaneous immunotherapy with high-dose of Humulus pollen allergen could obviously relieve the symptoms and improve the pulmonary function in mice with allergic asthma. It also elevated serum IgE and IgG level compared with model group. The Humulus pollen allergens could be identified in serum and the molecular weight of serum proteins that had the maximum binding to allergen were ~25 kDa and ~38 kDa in 7 cases (70%) and 6 cases (60%), respectively.
Conclusion:
Subcutaneous immunotherapy (high-dose) could effectively alleviate airway hyperresponsiveness and reduce airway inflammatory infiltration in allergic asthmatic mice.
Related Concept Videos
Allergic Reactions
Tumor Immunotherapy
Asthma-I: Introduction
Allergic Drug Reactions
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Asthma-III: Symptoms and Complications
Classification of Asthma

